{"name": "NGM Biopharmaceuticals",
 "permalink": "ngm-biopharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/ngm-biopharmaceuticals",
 "homepage_url": "http://www.ngmbio.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2007,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "biotech, diseases, metabolic, ngm, drug, stealth, biopharmaceuticals",
 "alias_list": "",
 "email_address": "info@ngmbio.com",
 "phone_number": "650.243.5555",
 "description": "Treatment of metabolic disease",
 "created_at": "Fri Jun 19 02:09:02 UTC 2009",
 "updated_at": "Wed May 08 10:42:36 UTC 2013",
 "overview": "\u003Cp\u003ENGM Biopharmaceuticals, Inc. is a privately held drug discovery company committed to identifying transformational medicines that dramatically improve human health. Based on emerging human clinical and genetic observations, the Company has devised several innovative experimental approaches to discover new therapies for the treatment of metabolic and cardiovascular diseases. Our current focus is on the gastrointestinal endocrine system, with an aim to identify novel factors implicated in the pathogenesis of type 2 diabetes and the apparent resolution of this grievous disease in patients who have undergone gastric bypass surgery.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       60],
      "assets/images/resized/0004/9534/49534v1-max-150x150.jpg"],
     [[185,
       75],
      "assets/images/resized/0004/9534/49534v1-max-250x250.jpg"],
     [[185,
       75],
      "assets/images/resized/0004/9534/49534v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "William",
      "last_name": "J. Rieflin",
      "permalink": "william-j-rieflin",
      "image": null}},
   {"is_past": false,
    "title": "Founder, President and Chief Scientific Officer",
    "person":
     {"first_name": "Jin-Long",
      "last_name": "Chen",
      "permalink": "jin-long-chen",
      "image":
       {"available_sizes":
         [[[80,
            92],
           "assets/images/resized/0004/9536/49536v1-max-150x150.jpg"],
          [[80,
            92],
           "assets/images/resized/0004/9536/49536v1-max-250x250.jpg"],
          [[80,
            92],
           "assets/images/resized/0004/9536/49536v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "Luis",
      "last_name": "Bayol",
      "permalink": "luis-bayol",
      "image":
       {"available_sizes":
         [[[80,
            92],
           "assets/images/resized/0004/9537/49537v1-max-150x150.jpg"],
          [[80,
            92],
           "assets/images/resized/0004/9537/49537v1-max-250x250.jpg"],
          [[80,
            92],
           "assets/images/resized/0004/9537/49537v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Board Director",
    "person":
     {"first_name": "Peter",
      "last_name": "Svennilson",
      "permalink": "peter-svennilson",
      "image": null}},
   {"is_past": true,
    "title": "CEO",
    "person":
     {"first_name": "David",
      "last_name": "V. Goeddel",
      "permalink": "david-v-goeddel",
      "image":
       {"available_sizes":
         [[[80,
            92],
           "assets/images/resized/0004/9535/49535v1-max-150x150.jpg"],
          [[80,
            92],
           "assets/images/resized/0004/9535/49535v1-max-250x250.jpg"],
          [[80,
            92],
           "assets/images/resized/0004/9535/49535v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$90.8M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "",
    "source_description": "Capital Funding Report",
    "raised_amount": 24550000.0,
    "raised_currency_code": "USD",
    "funded_year": 2008,
    "funded_month": 2,
    "funded_day": 1,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "The Column Group",
         "permalink": "the-column-group",
         "image":
          {"available_sizes":
            [[[150,
               105],
              "assets/images/resized/0004/9539/49539v1-max-150x150.png"],
             [[230,
               162],
              "assets/images/resized/0004/9539/49539v1-max-250x250.png"],
             [[230,
               162],
              "assets/images/resized/0004/9539/49539v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Prospect Venture Partners",
         "permalink": "prospect-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               81],
              "assets/images/resized/0003/4207/34207v1-max-150x150.png"],
             [[195,
               106],
              "assets/images/resized/0003/4207/34207v1-max-250x250.png"],
             [[195,
               106],
              "assets/images/resized/0003/4207/34207v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Rho Capital Partners",
         "permalink": "rho-capital-ventures",
         "image":
          {"available_sizes":
            [[[123,
               73],
              "assets/images/resized/0002/8603/28603v5-max-150x150.jpg"],
             [[123,
               73],
              "assets/images/resized/0002/8603/28603v5-max-250x250.jpg"],
             [[123,
               73],
              "assets/images/resized/0002/8603/28603v5-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "a",
    "source_url": "http://www.sec.gov/Archives/edgar/data/1426332/000142633209000004/xslFormDX01/primary_doc.xml",
    "source_description": "SEC D",
    "raised_amount": 2200000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 12,
    "funded_day": 22,
    "investments":
     []},
   {"round_code": "b",
    "source_url": "http://www.fiercebiotech.com/story/ngm-lands-51m/2010-03-15?utm_medium=rss\u0026utm_source=rss",
    "source_description": "NGM lands $51M for preclinical diabetes work",
    "raised_amount": 51000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 3,
    "funded_day": 15,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Tichenor Ventures",
         "permalink": "tichenor-ventures",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Prospect Venture Partners",
         "permalink": "prospect-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               81],
              "assets/images/resized/0003/4207/34207v1-max-150x150.png"],
             [[195,
               106],
              "assets/images/resized/0003/4207/34207v1-max-250x250.png"],
             [[195,
               106],
              "assets/images/resized/0003/4207/34207v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Rho Capital Partners",
         "permalink": "rho-capital-ventures",
         "image":
          {"available_sizes":
            [[[123,
               73],
              "assets/images/resized/0002/8603/28603v5-max-150x150.jpg"],
             [[123,
               73],
              "assets/images/resized/0002/8603/28603v5-max-250x250.jpg"],
             [[123,
               73],
              "assets/images/resized/0002/8603/28603v5-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "partial",
    "source_url": "http://www.fiercebiotech.com/story/ngm-raises-13m-cardiometabolic-rd-work/2013-05-07?utm_source=rss\u0026utm_medium=rss",
    "source_description": "NGM raises $13M for cardio/metabolic R\u0026D work",
    "raised_amount": 13000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 5,
    "funded_day": 7,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "630 Gateway Blvd",
    "address2": "",
    "zip_code": "94080-7014",
    "city": "South San Francisco",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": 37.656246,
    "longitude": -122.399735}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        80],
       "assets/images/resized/0004/9533/49533v1-max-150x150.jpg"],
      [[250,
        133],
       "assets/images/resized/0004/9533/49533v1-max-250x250.jpg"],
      [[450,
        240],
       "assets/images/resized/0004/9533/49533v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}